A phase 2a study to investigate drug–drug interactions between escalating doses of AT2220 (duvoglustat hydrochloride) and acid alfa-glucosidase in subjects with Pompe disease

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Kishnani, P; Tarnopolsky, M; Sivakumar, K; Roberts, M; Byrne, B; Goker-Alpan, O; Guter, K; Pervaiz, MA; Dasouki, M; Mozaffar, T; Finanger, E; Johnson, F; Boudes, P

Published Date

  • February 2013

Published In

Volume / Issue

  • 108 / 2

Start / End Page

  • S54 - S54

Published By

International Standard Serial Number (ISSN)

  • 1096-7192

Digital Object Identifier (DOI)

  • 10.1016/j.ymgme.2012.11.131